TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Stavanger Urologiske Senter AS
Closing information (x1000 EUR)
| Closing information | 2019/12 | 2018/12 | 2017/12 |
| Turnover |
1,130
|
1,058
|
1,132 |
| Financial expenses |
2
|
37
|
1 |
| Earnings before taxes |
651
|
409
|
451 |
| Total assets |
1,052
|
841
|
640 |
| Current assets |
987
|
760
|
532 |
| Current liabilities |
439
|
259
|
268 |
| Equity capital |
612
|
583
|
372 |
| - share capital |
10
|
10
|
10 |
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Solvency |
58.2%
|
69.3%
|
58.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
57.6%
|
38.7%
|
39.8% |
| Return on assets (ROA) |
62.1%
|
53.0%
|
70.6% |
| Current ratio |
224.8%
|
293.4%
|
198.5% |
| Return on equity (ROE) |
106.4%
|
70.2%
|
121.2% |
| Change turnover |
54
|
-53
|
-56 |
| Change turnover % |
5%
|
-5%
|
-5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.